Dark Forest Capital Management’s BridgeBio Pharma BBIO Stock Holding History

Dark Forest Capital Management’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,857	Closed	-$252K	–	982
2025 Q3	$252K	Sell	4,857 -1,440	-23%	-$70.2K	0.01%	1056
2025 Q2	$272K	Sell	6,297 -24,600	-80%	-$895K	0.01%	1036
2025 Q1	$1.07M	Buy	+30,897	New	+$1.04M	0.05%	663
2023 Q1	–	Sell	-1,270	Closed	-$9.68K	–	1181
2022 Q4	$9.68K	Buy	+1,270	New	+$12.2K	﹤0.01%	753
2022 Q2	–	Sell	-6,096	Closed	-$61K	–	904
2022 Q1	$61K	Buy	6,096 +5,430	+815%	+$55.7K	0.01%	582
2021 Q4	$11K	Buy	+666	New	+$28.2K	﹤0.01%	876

Other funds holding BBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dark Forest Capital Management's BBIO Position: Q4 2025 in Review

Dark Forest Capital Management sold out of BridgeBio Pharma (BBIO) in Q4 2025, closing a stake of 4,857 shares — an estimated $252K sold.

Dark Forest Capital Management first reported a position in BBIO in Q4 2021 and held it in 6 quarters. The position peaked at $1.07M in Q1 2025. 433 funds tracked by Wall St. Rank hold BBIO as of Q4 2025.

Dark Forest Capital Management reported no remaining BridgeBio Pharma position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 4,857 BridgeBio Pharma shares in Q4 2025, an estimated $252K.
Dark Forest Capital Management first reported a position in BridgeBio Pharma in Q4 2021 and held it in 6 quarters.
Dark Forest Capital Management's BridgeBio Pharma position peaked at $1.07M in Q1 2025.
433 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.